Thermo Fisher Scientific Advances T-cell Engineering With New Viral and Non-viral Platforms

Share Article

In this webinar, which LabRoots will host October 19, attendees will learn different viral and non-viral delivery approaches used in T cell engineering for cell and gene therapy applications.

Xavier de Mollerat du Jeu, Ph.D. Director, R&D, Cell Biology/Transfection at Thermo Fisher Scientific

Recent FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients more promise than ever for curative effects. However, many technical challenges in T cell gene delivery still remain in order for this therapy to become a standard of care practice.

In this webinar, which is sponsored by the team at Thermo Fisher Scientific, participants will learn from the current industry trends and challenges of cell and gene therapy manufacturing and gain a better understanding of the benefits of innovative new upstream technologies for virus generation in suspension.

They will receive an overview of the new solutions from Thermo Fisher for small-to-large-scale serum-free, suspension lentiviral production – LV-MAX™ Lentiviral Production System. This will include new editing tools for primary T cells that increase knock-in and knock-out efficiency and addresses non-viral delivery barriers through protocol optimization.

Dr. Xavier de Mollerat du Jeu, the director of research and development of Cell Biology/Transfection at Thermo Fisher Scientific, will be the speaker for this event.

de Mollerat du Jeu studied molecular biology and plant physiology at the University of Montpellier II in France and received his doctorate in human genetics from Clemson University. As a director of R&D transfection group at Thermo Fisher Scientific, he is working on creating and improving new nucleic acids delivery for both research and therapeutic applications.

LabRoots will host the webinar October 19, 2017, starting at 8:00 a.m. PDT, 11:00 a.m. EDT. To read more about that this event, discover the continuing education credits offered, or to register for this event, click here.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website